DANVERS, Massachusetts & SEOUL, Korea- June 4, 2008—NeuroLogica Corporation and its Korean distribution partner, Dong Kang Medical Systems Co.,Ltd., announced that the CereTom(R) has received clearance from the Korean Food and Drug Administration (KFDA) for medical capital device imaging.
“We are thrilled that the CereTom has cleared Korean FDA,” said Eric M. Bailey, CEO and President of NeuroLogica Corporation. “South Korea is one of the most innovative and medically advanced countries in Asia, we are confident that the CereTom will improve the standard of care for critically ill patients with neurological emergencies. Our distribution partner, Dong Kang, Co. has an excellent reputation at the best medical institutions in South Korea. We are pleased that they will be representing the CereTom.”
source: NeuroLogica
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment